Anti-Leakage Surgical Kit for Filling Cavities with Therapeutic Agents

The University of Hong Kong Background It is estimated that 60%-80% of a population will experience low back pain in life time. At least 40% of subject with chronic back pain is due to intervertebral disc degeneration. Regenerative medicine strategies are under intensive investigation for the treatment of degenerated intervertebral discs. These strategies will use […]

Methods for The Generation of Self Renewing Endodermal Precursor Populations

Children’s Hospital of Philadelphia Background Cell-based therapies for disease of endodermally derived organs such as the liver, pancreas, and intestines have gained significant interest. In addition to cell-based treatment strategies, there is a proven value in screening drugs in cellular models of the organ systems during development process. Commonly this screening is performed on induced […]

Topology Agnostic Detection and Location of Fault in DC Microgrid Using Local Measurements

Clemson University Background This topology agnostic fault detection and location technology is the first such technology that is system-independent, uses only local measurements, and is closed form (non-iterative). Combining these attributes allows this technology to operate quickly to meet the needs of the growing DC microgrid market. This speed advantage bridges a major challenge for […]

Fecal Microbial Biomarkers for Non-Alcoholic Fatty Liver Disease

The University of Hong Kong Background Non-alcoholic fatty liver disease (NAFLD) refers to a wide range of liver conditions caused by the deposition of fat in liver. The cause of NAFLD is not clear, and the NAFLD is one of the most common diseases in the United States and Western Countries. The prevalence of nonalcoholic […]

Mironid Ltd: Innovative Drug Discovery

University of Strathclyde Background Mironid Limited is an innovative drug discovery company that develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. This allows access to multiple therapeutic areas for exploitation. Current drug discovery pipeline is aimed at developing novel treatments for degenerative kidney diseases, chronic inflammatory diseases and cancer. […]

ULab: A Comprehensive Online Equipment Management and Booking Platform

University of Strathclyde Background Increasingly research lab managers are called upon to report on the usage of their labs and equipment, incidents, maintenance records and more. Without a proper management system in place, this can be very challenging. ULab was created to make the lab manager’s life easier. Over the years the functionality has increased […]

PAL Technologies Ltd: Clinical Tools for Patient-centred Health Monitoring

University of Strathclyde Background PAL Technologies is an award-winning company providing clinical tools for the patient-centred measurement of free-living, everyday activities and behaviour, providing researchers and clinicians with robust evidence for treatment interventions and disease-related risks. Based on more than 25 years of R&D across a range of patient groups, PAL’s miniaturised single sensor platform […]

ENOUGH Ltd: Mycoprotein Food Ingredient

University of Strathclyde Background ENOUGH’s purpose is to ‘make protein sustainable’. Using fermentation to meet future food protein needs is widely recognised as the most effective solution to feed a growing planet. ENOUGH produces ABUNDA® mycoprotein, a complete food ingredient containing all essential amino acids as well as being high in dietary fibre. It is […]

DxCover Ltd: Blood Analysis Platform

University of Strathclyde Background DxCover are developing a multi-cancer platform powered by DxCover AI Engine, with the first application in earlier diagnosis of brain tumours. The DxCover platform combines novel hardware with artificial intelligence algorithms to analyse a patient’s blood and detect the presence or absence of disease. Technology Overview DxCover platform: The DxCover platform […]

Photo-Responsive Carrier for Hydrophobic Small Molecule Delivery at Target Site

The University of Hong Kong Background Retinoblastoma is a severe eye cancer of infancy and childhood and can cause blindness or even death. Currently, the invasive intravitreal drug administration used in clinics is unpleasant for patients and can lead to side effects such as ocular haemorrhage, endophthalmitis and retinal detachment, etc. Thus, effective drug administration […]